Lung cancer is one of the deadliest diseases in the world. It is a type of cancer that affects the lungs or can spread from other parts of the body to the lungs. Lung cancer is the second most common type of cancer and the leading cause of cancer-related death in the United States.
Two main types of lung cancer
Lung cancer occurs when abnormal cells in the lungs multiply in an uncontrolled manner. This uncontrolled cell production can form a tumour, which can spread to other parts of the body. There are two main types of lung cancer, small cell lung cancer and non-small cell lung cancer; most lung cancer cases are non-small cell lung cancer.
Non-small cell lung cancer is typically treated with surgery to remove the tumour, while small cell lung cancer is primarily treated with a combination of chemotherapy and radiation. Treatment for lung cancer depends on the type and stage of cancer, as well as the patient’s overall health.
Prognosis of lung cancer
The prognosis of lung cancer is often not good. The five-year survival rate for all types is only 18%. It is especially dangerous for smokers, with a five-year survival rate of only 8%. The chances for survival also depend on the stage of cancer at diagnosis and the patient’s health.
There are several risk factors for lung cancer. The most common cause is smoking, while exposure to certain chemicals, industrial pollutants and asbestos can also increase risk. Additionally, those with a family history of lung cancer, radiation therapy to the chest, and certain genetic mutations are more likely to develop the disease.
Risk of developing lung cancer
While many factors can increase the risk of developing lung cancer, there are also ways to reduce the risk. Quitting smoking is the most important way to reduce the risk, as is avoiding secondhand smoke and avoiding exposure to known carcinogens. Additionally, regular screening of high-risk individuals can detect cancer in its earliest stages and improve the chances of successful treatment.
In conclusion, lung cancer is one of the deadliest diseases in the world with a low five-year survival rate. Knowing the risk factors and how to reduce them is an important part of prevention and may help increase survival rates. Early diagnosis and treatment of lung cancer can also improve chances of survival and is essential for a successful outcome for those suffering from this deadly disease.
Is an oral cancer drug
Alectinib 150mg Cap, also known by its brand name Alecensa, is an oral cancer drug used to treat non-small-cell lung cancer (NSCLC). Alectinib works by blocking certain proteins called anaplastic lymphoma kinase (ALK). ALK proteins are found in a certain type of cell that helps cancer cells to spread, leading to lung cancer. Blocking these proteins with Alectinib helps to stop cancer cells from spreading and can slow their growth.
Alectinib is typically used to treat lung cancer that has already spread throughout the body (metastasized). It’s generally used after other types of treatments such as surgery, radiation, and chemotherapy have failed to control cancer. Alectinib is also sometimes used in conjunction with other cancer treatments to improve the effect.
Dose of its administration
Alectinib is taken in pill form, usually two capsules taken twice a day. The dose is usually 300 mg per dose, and it’s important that you take the drug at the same time every day in order to get the full benefit of the drug. It’s also important to take Alectinib with food or a snack to help reduce stomach upset.
Effects of its action
In clinical trials, Alectinib was found to be effective in some patients in controlling their lung cancer. About 71% of those taking Alectinib saw a decrease in their tumour size and 25% had their cancer completely eliminated. Alectinib also had fewer side effects than chemotherapy, with most side effects being milder than those of chemotherapy. The most commonly reported side effects to include fatigue, nausea, vomiting, joint pain, constipation, and muscle pain.
Alectinib is not used to treat all types of lung cancer, so it’s important to talk with your doctor if you think Alectinib may be the right treatment for you. It’s also important to be aware of any potential side effects and to tell your doctor if you experience any concerning ones.
FAQs
- When does lung cancer occur?
Lung cancer occurs when abnormal cells in the lungs multiply in an uncontrolled manner.
- What are the main types of lung cancer?
small cell lung cancer and non-small cell lung cancer.
- How is non-small cell lung cancer treated?
Non-small cell lung cancer is typically treated with surgery to remove the tumour.